IP Library › Granted Patent US 9,238,221
Granted Patent B2
US 9,238,221 · App. 14/603,477 · Granted Jan 19, 2016

Curable compositions and membranes

Inventors: Bastiaan Van Berchum (Tilburg, NL); Jacko Hessing (Tilburg, NL); Harro Antheunis (Tilburg, NL)
Assignee: Fujifilm Manufacturing Europe BV
B01J39/20B01J47/12B05D3/067B05D3/068C02F1/42C02F1/4691C02F1/4693C02F1/4695C08F220/58H01M8/102H01M8/103H01M8/227C02F2201/46115H01M2008/1095H01M2300/0082Y02E60/521
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,221
App. No.
14/603,477
Granted
Jan 19, 2016
Kind
B2
Abstract

A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.5. The compositions are useful for preparing ion exchange membranes.

Claims (26)

1. A membrane obtained by a process comprising the following steps:

applying a curable composition to a support; and

curing the composition to form a membrane;

wherein the curable composition comprises:

(i) 7.47 to 43.33 wt % crosslinker comprising at least two acrylamide groups;

(ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group;

(iii) 15 to 45 wt % solvent; and

(iv) 0 to 10 wt % of free radical initiator;

wherein the molar ratio of (i):(ii) is from 0.1 to 1.5.

2. The membrane according to claim 1 wherein (a) the molar ratio of (i):(ii) is from 0.1 to 1.0; (b) the ethylenically unsaturated group is an acrylamide group or a methacrylamide group; and (c) the composition contains 20 to 40 wt % solvent.

3. The membrane according to claim 1 wherein (a) the composition comprises 20 to 40 wt % solvent; (b) the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 85 wt %; (c) the solvent comprises at least 40 wt % water; and (d) the molar ratio of (i):(ii) is from 0.13 to 0.7.

4. The membrane according to claim 1 wherein the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 85 wt %.

5. The membrane according to claim 1 wherein the solvent comprises at least 40 wt % water.

6. The membrane according to claim 1 wherein the composition comprises 0.005 to 10 wt % photoinitiator.

7. The membrane according to claim 1 wherein the composition is free from ethylenically unsaturated compounds other than components (i) and (ii).

8. The membrane according to claim 1 wherein the curable composition comprises:

(i) 8 to 16 wt % crosslinker comprising at least two acrylamide groups;

(ii) 40 to 60 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group;

(iii) 22 to 40 wt % solvent; and

(iv) 0.01 to 2 wt % of photoinitiator;

wherein the molar ratio of (i):(ii) is from 0.1 to 1.0.

9. The membrane according to claim 1 wherein the curing is performed using electron beam or UV radiation.

10. The membrane according to claim 1 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds.

11. The membrane according to claim 1 wherein the curable composition is applied continuously to a moving support using a manufacturing unit comprising a curable composition application station, an irradiation source for curing the composition, and a membrane collecting station and wherein the support moves from the curable composition application station to the irradiation source and to the membrane collecting station.

12. The membrane according to claim 8 wherein the curing is performed using electron beam or UV radiation.

13. The membrane according to claim 8 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds.

Priority Claims (1)
GB 0921949.4 · Dec 16, 2009 · national
Continuity (2)
Division 13516320
Related Publication 20150132681A1 · May 14, 2015